Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies

CONCLUSIONS: DM is associated with poor survival outcomes in patients with B-cell NHL, which is consistent in patients with DLBCL. Concurrent metformin use in DM patients with NHL may be associated with improved survival outcomes.PMID:34593361 | DOI:10.1016/j.clml.2021.08.013

Source: Clinical Lymphoma and Myeloma - October 1, 2021 Category: Cancer & Oncology Authors: Zhen Han Hong Xu Meiqing Zhao Fanjing Jing Hongwei Xue Shuxin Xiao Source Type: research